Single-use Flexible Bronchoscope
Hunan Vathin Medical Instrument Co., Ltd. · Decision date Sep 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 23, 2026 for K261637, a Single-use Flexible Bronchoscope submitted by Hunan Vathin Medical Instrument Co., Ltd. The application was received May 18, 2026 and reviewed under regulation 874.4680 with product code EOQ; the regulation medical specialty and review panel are both Ear, Nose, and Throat. The record describes a traditional 510(k) that was not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.
SESE in a 510(k) means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The available record does not identify the predicate device, the specific model or component changes, or the full indications for use. One document excerpt lists biocompatibility tests described as recommended, including cytotoxicity, irritation, sensitization, pyrogenicity, and acute systemic toxicity, but the excerpt is truncated and does not report results.
The public record does not include the decision statement or summary basis, so the clinical evidence supporting equivalence and any labeling limitations remain unknown from these sources.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Sep 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261637
- Regulatory pathway
- 510(k) premarket notification
- Product code
- EOQ
- Decision code
- SESE
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Bronchoscope (Flexible Or Rigid).
- Product code
- EOQ
- FDA device class
- 2
FDA decision timeline
K261637 received
Application receipt date recorded by FDA.
K261637 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code EOQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Ambu A/S | 510(k) clearance | Sep 16, 2026 | FDA | |
| Flexicare Medical Limited. | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hunan Vathin Medical Instrument Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Xiangtan
Sources and methodology
- Original FDA record: K261637
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
